HIV Annual Update: HIV Care in 2022 and Beyond

Download All
Watch the discussion and download slides from this engaging symposium reviewing the most important clinical developments in HIV management from the past year. Topics covered include evolving options for first-line ART and switch strategies for virologically suppressed patients, optimized regimens for patients with extensive treatment experience, new and expanding options for HIV prevention, the latest data and guidance on weight gain with ART, future innovations in HIV management, mitigating the effects of the COVID-19 pandemic on HIV care, and addressing racial inequities across the healthcare system.
Karine Lacombe, MD, PhD
Babafemi Taiwo, MBBS


My take on how 2-drug regimens and investigational agents are expanding our options for successful antiretroviral therapy in treatment-naive patients, virally suppressed patients switching regimens, and potentially to patients experiencing virologic failure.

Babafemi Taiwo, MBBS Released: November 5, 2021

Thoughts on how investigational, long-acting 2-drug regimens involving drugs with novel mechanisms of action may expand treatment options not only for treatment-experienced patients, but also for ART-naive patients in key populations with specific needs.

Karine Lacombe, MD, PhD Released: November 30, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings